JNCE

Jounce Therapeutics, Inc. Common Stock

Delisted

JNCE was delisted on the 3rd of May, 2023.

77 hedge funds and large institutions have $80.2M invested in Jounce Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 29 increasing their positions, 22 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$57K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$528K
2 +$360K
3 +$333K
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$217K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$215K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$34.1M
2
$10.2M
3
$4.69M
4
$4.21M
5
$2.88M
6
$2.71M
7
$2.46M
8
$2.11M
9
$1.76M
10
$1.4M
11
$1.4M
12
$1.2M
13
$743K
14
$627K
15
$602K
16
$557K
17
$528K
18
$515K
19
$511K
20
$469K
21
$456K
22
$440K
23
$409K
24
$377K
25
$360K